BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21886452)

  • 21. Prevalence and molecular characteristics of DNA mismatch repair deficient endometrial cancer in a Japanese hospital-based population.
    Yamamoto A; Yamaguchi T; Suzuki O; Ito T; Chika N; Kamae N; Tamaru JI; Nagai T; Seki H; Arai T; Tachikawa T; Akagi K; Eguchi H; Okazaki Y; Ishida H
    Jpn J Clin Oncol; 2021 Jan; 51(1):60-69. PubMed ID: 32844218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mismatch repair deficiency and prognostic significance in patients with low-risk endometrioid endometrial cancers.
    Kim SR; Pina A; Albert A; McAlpine JN; Wolber R; Gilks B; Carey MS; Kwon JS
    Int J Gynecol Cancer; 2020 Jun; 30(6):783-788. PubMed ID: 32354793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological features in endometrial carcinoma associated with Lynch syndrome in China.
    Wang Y; Xue F; Broaddus RR; Tao X; Xie SS; Zhu Y
    Int J Gynecol Cancer; 2009 May; 19(4):651-6. PubMed ID: 19509565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.
    Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T
    Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
    Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic characteristics of double primary endometrial and colorectal cancers in a single institution.
    Lee HJ; Choi MC; Jang JH; Jung SG; Park H; Joo WD; Kim TH; Lee C; Lee JH
    J Obstet Gynaecol Res; 2018 May; 44(5):944-950. PubMed ID: 29442399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lynch syndrome and endometrial cancer].
    Bats AS; Rossi L; Le Frere-Belda MA; Narjoz C; Cournou C; Gosset M; Ngo C; Delomenie M; Nos C; Blons H; Laurent-Puig P; Lecuru F
    Bull Cancer; 2017 Dec; 104(12):1013-1021. PubMed ID: 29061399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients.
    Walsh MD; Cummings MC; Buchanan DD; Dambacher WM; Arnold S; McKeone D; Byrnes R; Barker MA; Leggett BA; Gattas M; Jass JR; Spurdle AB; Young J; Obermair A
    Clin Cancer Res; 2008 Mar; 14(6):1692-700. PubMed ID: 18310315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
    Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
    Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic Characteristics of Endometrial Cancer in Lynch Syndrome: A French Multicenter Study.
    Rossi L; Le Frere-Belda MA; Laurent-Puig P; Buecher B; De Pauw A; Stoppa-Lyonnet D; Canlorbe G; Caron O; Borghese B; Colas C; Delhomelle H; Chabbert-Buffet N; Grandjouan S; Lecuru F; Bats AS
    Int J Gynecol Cancer; 2017 Jun; 27(5):953-960. PubMed ID: 28525912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.
    Pande M; Wei C; Chen J; Amos CI; Lynch PM; Lu KH; Lucio LA; Boyd-Rogers SG; Bannon SA; Mork ME; Frazier ML
    Fam Cancer; 2012 Sep; 11(3):441-7. PubMed ID: 22714864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening.
    Carr C; Son J; Yao M; Priyadarshini A; Marquard J; Vargas R; Michener C; AlHilli MM
    Gynecol Oncol; 2020 Dec; 159(3):712-720. PubMed ID: 33046272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A prospective cohort study about the screening tests of mismatch repair protein and clinical criteria for Lynch syndrome associated endometrial carcinoma].
    Chao XP; Li L; Wu M; Ma SQ; Tan XJ; Zhong S; Lang JH
    Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1178-1183. PubMed ID: 31006223
    [No Abstract]   [Full Text] [Related]  

  • 34. Endometrial Cancer Diagnosed at an Early Stage during Lynch Syndrome Surveillance: A Case Report.
    Umemiya M; Horikawa N; Kanai A; Saeki A; Ida K; Makio S; Yoshida T; Tsuji M; Gou R; Tani H; Usui T; Kosaka K
    Case Rep Oncol; 2023; 16(1):634-639. PubMed ID: 37933313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome and management of pathological stage I endometrial carcinoma patients with involvement of the lower uterine segment.
    Phelan C; Montag AG; Rotmensch J; Waggoner SE; Yamada SD; Mundt AJ
    Gynecol Oncol; 2001 Dec; 83(3):513-7. PubMed ID: 11733964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
    Kahn RM; Gordhandas S; Maddy BP; Baltich Nelson B; Askin G; Christos PJ; Caputo TA; Chapman-Davis E; Holcomb K; Frey MK
    Cancer; 2019 Sep; 125(18):3172-3183. PubMed ID: 31150123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular carcinogenesis of endometrial cancer.
    Liu FS
    Taiwan J Obstet Gynecol; 2007 Mar; 46(1):26-32. PubMed ID: 17389185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].
    Schneider R; Schneider C; Büttner R; Reinacher-Schick A; Tannapfel A; Fürst A; Rüschoff J; Jakobeit C; Royer-Pokora B; Möslein G
    Zentralbl Chir; 2015 Dec; 140(6):591-9. PubMed ID: 25372301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct clinical and genetic mutation characteristics in sporadic and Lynch syndrome-associated endometrial cancer in a Chinese population.
    Sun P; Shen Y; Wang T; He Y; Zhang Y; Tian W; Yang B; Hu Y
    Cancer Epidemiol; 2021 Aug; 73():101934. PubMed ID: 34000661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study.
    Bucksch K; Zachariae S; Aretz S; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Kloor M; von Knebel Doeberitz M; Morak M; Möslein G; Nattermann J; Perne C; Rahner N; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vangala DB; Weitz J; Loeffler M; Engel C;
    BMC Cancer; 2020 May; 20(1):460. PubMed ID: 32448342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.